1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 1: FROC parameters of gliomas and normal contralateral thalamus of patients with low-grade and high-grade gliomas
D (μm2/ms) β μ (μm) Gliomas LG 1.54 ± 0.35 0.85 ± 0.05 8.43 ± 0.63 HG 1.19 ± 0.36 0.77 ± 0.06 8.01 ± 0.59 P valuea <.001 <.001 .011 NCTH LG 0.76 ± 0.06 0.78 ± 0.03 7.33 ± 0.38 HG 0.76 ± 0.04 0.78 ± 0.03 7.34 ± 0.33 P valuea .876 .706 .890
Note:—NCTH indicates normal contralateral thalamus; LG, low-grade; HG, high-grade.
↵a Mann-Whitney U test.